内分泌相关治疗领域的创新型生物医药公司
2025.03.01,
2025.02.01, 安科生物
2021.01.09, 夏尔巴投资, Ascendis Pharma, 红杉资本中国, 奥博资本, Sofinnova Investments, 维梧资本
2021.01.01, HongShan红杉中国, 奥博资本, 夏尔巴投资, Cormorant, HBM Healthcare Investments, 鼎丰生科资本, Logos Capital, 晨岭资本, ASND, Vivo Capital, Sofinnova Investments
2019.02.01, Vivo Capital, ASND, Sofinnova Investments
Note: collected from public online reports, for reference only.